IP Verse

Biological Dosage Of Peptidoglycans - EP3102692

The patent EP3102692 was granted to Roquette Frres on Feb 16, 2022. The application was originally filed on Feb 5, 2015 under application number EP15708563A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3102692

ROQUETTE FRRES
Application Number
EP15708563A
Filing Date
Feb 5, 2015
Status
Patent Maintained As Amended
Jan 14, 2022
Grant Date
Feb 16, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALBEON INVEST ZRTOct 10, 2019KOVARIADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2012143647
INTERNATIONAL-SEARCH-REPORTFR2978774
INTERNATIONAL-SEARCH-REPORTGB2481267
INTERNATIONAL-SEARCH-REPORTWO2009115533
INTERNATIONAL-SEARCH-REPORTWO2012143647
INTERNATIONAL-SEARCH-REPORTWO2013178931
INTERNATIONAL-SEARCH-REPORTWO2014154651
OPPOSITIONWO2012143647
OPPOSITIONWO2014154651

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Goodman et al, J. Bacteriology, (19810000), vol. 146, pages 755 - 763-
OPPOSITION- NAKIMBUGWE D et al., "Cell wall substrate specificity of six different lysozymes and lysozyme inhibitory activity of bacterial extracts", FEMS Microbiol Lett, (20060421), vol. 259, pages 41 - 46-
OPPOSITION- RAU A, "The crystal structure of a bacterial lysozyme at atomic resolution", Dissertation, (20050601), XP055651708-
OPPOSITION- TIMMERMAN CP et al., "Induction of Release of Tumor Necrosis Factor from Human Monocytes by Staphylococci and Staphylococcal Peptidoglycans", Infect Immun, (19931000), vol. 61, no. 10, pages 4167 - 4172, XP055123665-
OPPOSITION- ERRIDGE C, "The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4", British Journal of Nutrition, (20110000), vol. 105, doi:10.1017/S0007114510003004, pages 15 - 23, XP002690888
OPPOSITION- NAKIMBUGWE D et al., "Cell wall substrate specificity of six different lysozymes and lysozyme inhibitory activity of bacterial extracts", FEMS Microbiol Lett, (20060421), vol. 259, pages 41 - 46, XP055650863
OPPOSITION- GREENBLATT J et al., "Activation of the Alternate Complement Pathway by Peptidoglycan from Streptococcal Cell Wall", Infect Immun, (19780100), vol. 19, no. 1, pages 296 - 303, XP055651688

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents